Charlotte Hubbert

Charlotte Hubbert currently works at Madrona Venture Group LLC, as Strategic Director from 2021, Beckman Research Institute of The City of Hope, as Director from 2021, City of Hope National Medical Center, as Director from 2021, Entrinsic, Inc. (Massachusetts), as Director from 2020, Society of Kauffman Fellows, as Member, and Lineage Cell Therapeutics, Inc., as Vice President-Corporate Development from 2024.
Dr. Hubbert also formerly worked at Synlogic Operating Co., Inc., as Director, Vir Biotechnology, Inc., as Director from 2017 to 2019, Life Science Washington, as Director, Synlogic, Inc., as Director, Lodo Therapeutics Corp., as Director, AgTech Accelerator Corp., as Director, Sera Prognostics, Inc., as Director, Vedanta Biosciences, Inc., as Director from 2018 to 2020, NS Wind Down Co., Inc., as Senior Director-Business Development, and Accelerator Services Corp, as Associate in 2009.
Dr. Hubbert received her doctorate degree in 2005 from Duke University and undergraduate degree from the University of Washington.